论文部分内容阅读
目的分析并总结β-受体阻滞剂治疗慢性充血性心力衰竭的临床效果与安全性。方法回顾性分析我院自2006年12月至2010年11月期间采用β-受体阻滞剂对100例慢性充血性心力衰竭患者实施治疗的过程,分析其临床有效性。结果治疗组与对照组显效例数分别为73例和32例,分别占73.0%和43.2%;两组有效例数均为11例,分别占11.0%和16.3%;两组总有效率分别为84.0%和59.5%;两组无效例数分别为16例和33例,分别占16%和40.5%。治疗组与对照组的组间总有效率差异明显(P<0.05),具统计学意义。治疗组平均起效时间为5.4 d。对照组平均起效时间为8.6 d。结论在使用常规治疗心衰的药物的前提下再使用β-受体阻滞剂能够显著改善患者的心力衰竭症状。
Objective To analyze and summarize the clinical effects and safety of β-blocker in the treatment of chronic congestive heart failure. Methods A retrospective analysis of our hospital from December 2006 to November 2010 using β-blockers in 100 patients with chronic congestive heart failure in the implementation of the treatment process, analysis of its clinical effectiveness. Results The number of effective cases in the treatment group and the control group were 73 cases and 32 cases, accounting for 73.0% and 43.2% respectively. The effective cases in both groups were 11 cases (11.0% and 16.3%, respectively). The total effective rates in the two groups were 84.0% and 59.5% respectively. The number of invalid cases in both groups was 16 and 33, accounting for 16% and 40.5% respectively. There was significant difference between the two groups in the total effective rate (P <0.05) between the treatment group and the control group, with statistical significance. The mean effective time of the treatment group was 5.4 days. The mean onset time in the control group was 8.6 days. Conclusion The use of β-blockers with conventional treatments of heart failure can significantly improve the symptoms of heart failure in patients.